BackAbCellera Biologics Overview

AbCellera Biologics Total Revenue

Revenue analysis for ABCL.

Quarterly Revenue

$8.31M
↑ 96.34% YoY

As of Mar 2026

Annual Revenue (TTM)

$79.21M
↑ 242.67% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin